RecruitingNot ApplicableNCT05479461

Technology-enabled Management Versus Usual Care for Blood Pressure

A Two-arm Parallel Randomized Clinical Trial of Implementation of Technology-enabled Management Versus Usual Care for Blood Pressure

Sponsor

Stanford University

Enrollment

200 participants

Start Date

Jun 13, 2023

Study Type

INTERVENTIONAL

Conditions

Two arm parallel randomized clinical trial

Min Age: 30 YearsMax Age: 90 Years

Age 30-90 yrs.
Smartphone ownership
Office SBP: ≥ 140 mm Hg
≤ 2 current anti-HTN meds
Able to add or dose-increase at least 2 of the following classes of medications: ACE-I/ARB, diuretic, calcium channel blocker, beta-blocker, mineralocorticoid receptor antagonists (i.e., at least 2 classes are available for addition or dose- increases after excluding intolerant medications and medications currently at maximum dose)
English or Spanish-speakers

Heart failure with reduced ejection fraction (EF \< 40%)
ESRD (GFR \<15)
Renal replacement therapy
Pregnant
Myocardial infarction or stroke within preceding 6 months
Hospitalization for hypertensive emergency or malignant hypertension within preceding 6 months
Prior solid organ transplantation
At the clinical discretion of the investigators
Enrolled in another clinical study

OTHERUsual Care

The participants will receive usual care

OTHERDigital Hypertension Management System

Mobile health technology using physician- directed, semi-automated management of hypertension

Stanford Health Care

Palo Alto, California, United States

Morehouse School of Medicine

Atlanta, Georgia, United States

Lake Country Medical Group

Eatonton, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT05479461